Issue 10/2014
Content (9 Articles)
Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
Jürgen Beckmann, Ulrich Hagemann, Priya Bahri, Andrew Bate, Ian W. Boyd, Gerald J. Dal Pan, Brian D. Edwards, I. Ralph Edwards, Kenneth Hartigan-Go, Marie Lindquist, John McEwen, Yola Moride, Sten Olsson, Shanthi N. Pal, Rachida Soulaymani-Bencheikh, Marco Tuccori, Claudia P. Vaca, Ian C. K. Wong
Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet
G. Niklas Norén
Pharmacovigilance in China: Current Situation, Successes and Challenges
Li Zhang, Lisa Y. L. Wong, Ying He, Ian C. K. Wong
Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies
Joshua J. Gagne
Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art
Rave Harpaz, Alison Callahan, Suzanne Tamang, Yen Low, David Odgers, Sam Finlayson, Kenneth Jung, Paea LePendu, Nigam H. Shah
The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis
Jacqueline Flank, Lillian Sung, Christopher C. Dvorak, Wendy Spettigue, L. Lee Dupuis
Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK
Pernille Warrer, Lise Aagaard, Ebba Holme Hansen
Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events
Agata Ptaszynska, Kristina M. Johnsson, Shamik J. Parikh, Tjerk W. A. de Bruin, Anne Marie Apanovitch, James F. List